From Name:
From Email:
To Name:
To Email:

Optional Message:

Not so fast with immune therapy for breast cancer

from Forbes

Elaine Schattner writes: Since I began writing here at Forbes, it’s become harder to keep up with new oncology drugs. So many medicines are being tested, who can keep track of them all? Days ago, investigators reported results of a multinational trial of an immune drug, combined with chemotherapy, in patients with advanced triple negative breast cancer (TNBC), an aggressive form. Roche sponsored the study. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063